Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9195)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rahman R, Hammoud GM, Almashhrawi AA, Ahmed KT, Ibdah JA. Primary hepatocellular carcinoma and metabolic syndrome: An update. World J Gastrointest Oncol 2013; 5(9): 186-194 [PMID: 24069511 DOI: 10.4251/wjgo.v5.i9.186] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v5/i9/186.htm |
| Number | Citing Articles |
| 1 |
Filomena Morisco, Maria Guarino, Maria R. Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani. Metabolic disorders across hepatocellular carcinoma in Italy. Liver International 2018; 38(11): 2028 doi: 10.1111/liv.13877
|
| 2 |
Chiara Saponaro, Melania Gaggini, Fabrizia Carli, Amalia Gastaldelli. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. Nutrients 2015; 7(11): 9453 doi: 10.3390/nu7115475
|
| 3 |
Julius Dongsogo, Christopher Larbie. Association of metabolic syndrome with the risk of developing liver disease in chronic hepatitis B patients. African Journal of Biochemistry Research 2019; 13(2): 23 doi: 10.5897/AJBR2017.0956
|
| 4 |
Joseph Asemota, Olubunmi Oladunjoye, Atinuke Babalola, Ugonna Nwosu, Po-Hong S Liu, Adeolu O Oladunjoye, Nelsy Castro-Webb, Rebecca A Miksad. Comparison of Hepatocellular Carcinoma in Hispanics and Non-Hispanics Patients. Cureus 2021; doi: 10.7759/cureus.14884
|
| 5 |
Stephanie Mueller, Jérémy Huard, Katharina Waldow, Xiaoyun Huang, Lorenza A D'Alessandro, Sebastian Bohl, Kathleen Börner, Dirk Grimm, Steffen Klamt, Ursula Klingmüller, Marcel Schilling. T160‐phosphorylated CDK2 defines threshold for HGF‐dependent proliferation in primary hepatocytes. Molecular Systems Biology 2015; 11(3) doi: 10.15252/msb.20156032
|
| 6 |
Hiroyasu Sakai, Yohei Shirakami, Masahito Shimizu. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World Journal of Gastroenterology 2016; 22(1): 394-406 doi: 10.3748/wjg.v22.i1.394
|
| 7 |
Shengwei Li, Jin-He Guo, Jian Lu, Chao Wang, Hao Wang. Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization. Cancer Management and Research 2021; : 1637 doi: 10.2147/CMAR.S290983
|
| 8 |
Vivian Klungboonkrong, Dola Das, Gordon McLennan. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2017; 28(7): 949 doi: 10.1016/j.jvir.2017.03.002
|
| 9 |
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho, Yuan Xu. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/4956079
|
| 10 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 11 |
Allison J. Kasmari, Amy Welch, Guodong Liu, Doug Leslie, Thomas McGarrity, Thomas Riley. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome. The American Journal of Medicine 2017; 130(6): 746.e1 doi: 10.1016/j.amjmed.2016.12.029
|
| 12 |
Gabriel Schwartz, Julianne O. Darling, Malori Mindo, Lucia Damicis. Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma. Targeted Oncology 2020; 15(4): 549 doi: 10.1007/s11523-020-00736-8
|
| 13 |
Sim Y. Ong, Amanda J. Nicoll, Martin B. Delatycki. How should hyperferritinaemia be investigated and managed?. European Journal of Internal Medicine 2016; 33: 21 doi: 10.1016/j.ejim.2016.05.014
|
| 14 |
Kerstin Schütte, Christian Schulz, Janine Poranzke, Kai Antweiler, Jan Bornschein, Tina Bretschneider, Jörg Arend, Jens Ricke, Peter Malfertheiner. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-117
|
| 15 |
Richard S. Hoehn, Dennis J. Hanseman, Koffi Wima, Audrey E. Ertel, Ian M. Paquette, Daniel E. Abbott, Shimul A. Shah. Does race affect management and survival in hepatocellular carcinoma in the United States?. Surgery 2015; 158(5): 1244 doi: 10.1016/j.surg.2015.03.026
|
| 16 |
Michael C. Kew. Obesity as a cause of hepatocellular carcinoma. Annals of Hepatology 2015; 14(3): 299 doi: 10.1016/S1665-2681(19)31267-0
|
| 17 |
I. A. Khakuasheva, M. A. Umetov, L. A. Zheletezheva, A. M. Tkhamokov. The risk of hepatocellular carcinoma of the liver in non-alcoholic fatty liver disease: features of prevention and treatment. Experimental and Clinical Gastroenterology 2022; (9): 284 doi: 10.31146/1682-8658-ecg-205-9-284-289
|
| 18 |
Pia Edenvik, Loa Davidsdottir, Antti Oksanen, Bengt Isaksson, Rolf Hultcrantz, Per Stål. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?. Liver International 2015; 35(7): 1862 doi: 10.1111/liv.12764
|
| 19 |
Lin-Lin Cao, Yi Han, Yuanxiao Wang, Lin Pei, Zhihong Yue, Li Qin, Boyu Liu, Jingwen Cui, Mei Jia, Hui Wang. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.816748
|
| 20 |
Richard S. Hoehn, Dennis J. Hanseman, Vikrom K. Dhar, Derek E. Go, Michael J. Edwards, Shimul A. Shah. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations. Journal of the American College of Surgeons 2017; 224(4): 697 doi: 10.1016/j.jamcollsurg.2016.12.023
|
| 21 |
Norberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, Natalia Nuño-Lambarri, Paulina Vidal-Cevallos, Misael Uribe. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 583 doi: 10.2147/JHC.S283840
|
| 22 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 23 |
Xuan-vinh Kevin Nguyen, Jason Zhang, Ken Lee Chin, Stephen Bloom, Amanda J. Nicoll. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?. Nutrients 2022; 14(18): 3875 doi: 10.3390/nu14183875
|
| 24 |
Manuele Gori, Barbara Barbaro, Mario Arciello, Roberta Maggio, Carmela Viscomi, Alessia Longo, Clara Balsano. Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News?. Journal of Cellular Physiology 2014; 229(9): 1182 doi: 10.1002/jcp.24550
|
| 25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 26 |
Manuele Gori, Mario Arciello, Clara Balsano. MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/741465
|
| 27 |
Fatiha Nassir, Jamal Ibdah. Role of Mitochondria in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2014; 15(5): 8713 doi: 10.3390/ijms15058713
|
| 28 |
Fei Ji, Yao Liang, Shunjun Fu, Dubo Chen, XiuQin Cai, Shaoqiang Li, Baogang Peng, Lijian Liang, Yunpeng Hua. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy. HPB 2017; 19(8): 695 doi: 10.1016/j.hpb.2017.04.008
|
| 29 |
Luis Solorio, Hanping Wu, Christopher Hernandez, Mihika Gangolli, Agata A Exner.
Ultrasound-Guided Intratumoral Delivery of Doxorubicin from
in Situ
Forming Implants in a Hepatocellular Carcinoma Model
. Therapeutic Delivery 2016; 7(4): 201 doi: 10.4155/tde-2015-0008
|
| 30 |
Talya L. Dayton, Vasilena Gocheva, Kathryn M. Miller, William J. Israelsen, Arjun Bhutkar, Clary B. Clish, Shawn M. Davidson, Alba Luengo, Roderick T. Bronson, Tyler Jacks, Matthew G. Vander Heiden. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development 2016; 30(9): 1020 doi: 10.1101/gad.278549.116
|
| 31 |
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
|
| 32 |
I. Glory Josephine, K. Punnagai. In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) Cells. Biomedical and Pharmacology Journal 2019; 12(2): 901 doi: 10.13005/bpj/1715
|
| 33 |
Barbara Schellhaas. Diagnose geht auch ohne Biopsie. Im Focus Onkologie 2018; 21(4): 65 doi: 10.1007/s15015-018-3911-4
|
| 34 |
Gang Liu, Guojun Hou, Liang Li, Yixue Li, Weiping Zhou, Lei Liu. Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo. Oncotarget 2016; 7(22): 32607 doi: 10.18632/oncotarget.8927
|
| 35 |
Barbara Schellhaas. Leberkrebs-Diagnose geht auch ohne Biopsie. MMW - Fortschritte der Medizin 2018; 160(3): 59 doi: 10.1007/s15006-018-0203-z
|
| 36 |
Liang Feng, Peng Sun, Zhiyu Li, Ming Liu, Shibo Sun. Knockdown of PPP5C Inhibits Growth of Hepatocellular Carcinoma Cells In Vitro. Applied Biochemistry and Biotechnology 2015; 175(1): 526 doi: 10.1007/s12010-014-1281-8
|
| 37 |
Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão. Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping. Gastrointestinal Disorders 2024; 6(2): 402 doi: 10.3390/gidisord6020027
|
| 38 |
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
|
| 39 |
Khanh Nguyen, Kerri Jack, Weijing Sun. Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy. Diseases 2015; 4(1): 1 doi: 10.3390/diseases4010001
|
| 40 |
Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00762
|
| 41 |
Marcus Grohmann, Florian Wiede, Garron T. Dodd, Esteban N. Gurzov, Geraldine J. Ooi, Tariq Butt, Aliki A. Rasmiena, Supreet Kaur, Twishi Gulati, Pei K. Goh, Aislinn E. Treloar, Stuart Archer, Wendy A. Brown, Mathias Muller, Matthew J. Watt, Osamu Ohara, Catriona A. McLean, Tony Tiganis. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell 2018; 175(5): 1289 doi: 10.1016/j.cell.2018.09.053
|
| 42 |
Guang-Ping Qiu, Jie Liu. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers 2016; 20(10): 579 doi: 10.1089/gtmb.2016.0073
|
| 43 |
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and Cancer. Recent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
|
| 44 |
Barbara Schellhaas, Deike Strobel, Miriam Stumpf, Marion Ganslmayer, Lukas Pfeifer, Ruediger S. Goertz, Markus F. Neurath, Steffen Zopf. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts. European Journal of Gastroenterology & Hepatology 2018; 30(12): 1422 doi: 10.1097/MEG.0000000000001221
|
| 45 |
Clifford G. Tepper, Julie H. T. Dang, Susan L. Stewart, Dao M. Fang, Kimberly A. Wong, Stephenie Y. Liu, Ryan R. Davis, Doan Y. Dao, Jeffrey P. Gregg, Natalie J. Török, Moon S. Chen. High frequency of the PNPLA3 rs738409 [G] single‐nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease. Cancer 2018; 124(S7): 1583 doi: 10.1002/cncr.31122
|
| 46 |
Sheng Tan, Ming Zhang, Xinglong Shi, Keshuo Ding, Qiang Zhao, Qianying Guo, Hao Wang, Zhengsheng Wu, Yani Kang, Tao Zhu, Jielin Sun, Xiaodong Zhao. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01884-z
|
| 47 |
Weihao Chen, Yurong Wang, Qiuer Liang, Yunfei Cai, Xudong Chen, Yun Zhang, Ruixue Chen, Ya Xiao, Liguo Chen, Kieran Cooley. Efficacy and Safety of Aidi Injection Combined with Transcatheter Arterial Chemoembolization on Primary Hepatic Carcinoma: A Systematic Review and Meta‐Analysis. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/6376429
|
| 48 |
Francesca Gorini, Elisa Bustaffa, Davide Bolignano, Liliana Cori, Francesco Faita, Amalia Gastaldelli, Monica Interdonato, Fabizio Minichilli, Giancarlo Quattrone, Francesco Squadrito, Giovanni Tripepi, Cristina Vassalle, Fabrizio Bianchi. Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies. BMJ Open 2020; 10(5): e036160 doi: 10.1136/bmjopen-2019-036160
|
| 49 |
Pablo Muriel, Pedro López-Sánchez, Erika Ramos-Tovar. Fructose and the Liver. International Journal of Molecular Sciences 2021; 22(13): 6969 doi: 10.3390/ijms22136969
|
| 50 |
Yumi Kim, Sung Reul Kim, Kyounghae Kim, Su Jong Yu. Demographic, clinical and psychological predictors of malnutrition among people with liver cancer. European Journal of Oncology Nursing 2024; 68: 102497 doi: 10.1016/j.ejon.2023.102497
|
| 51 |
Nishika Sahini, Jürgen Borlak. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Progress in Lipid Research 2014; 54: 86 doi: 10.1016/j.plipres.2014.02.002
|
| 52 |
Paul Nderitu, Cecilia Bosco, Hans Garmo, Lars Holmberg, Håkan Malmström, Niklas Hammar, Göran Walldius, Ingmar Jungner, Paul Ross, Mieke Van Hemelrijck. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. International Journal of Cancer 2017; 141(6): 1148 doi: 10.1002/ijc.30818
|
| 53 |
Marie Liebig, Alireza Hassanzada, Malte Kämmerling, Berit Genz, Brigitte Vollmar, Kerstin Abshagen. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors. Experimental Biology and Medicine 2018; 243(1): 1 doi: 10.1177/1535370217738730
|
| 54 |
Iole Ferrara-Romeo, Paula Martínez, Maria A. Blasco, Arthur J. Lustig. Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice. PLOS ONE 2018; 13(10): e0204909 doi: 10.1371/journal.pone.0204909
|
| 55 |
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors. World Journal of Gastroenterology 2014; 20(36): 12945-12955 doi: 10.3748/wjg.v20.i36.12945
|
| 56 |
Gaspard d'Assignies, Cindy Fayard, Helena Leitao, Toni Alfaiate, Florence Tubach, Safi Dokmak, Valérie Paradis, Bernard E. Van Beers, Maxime Ronot, Valérie Vilgrain. Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resection. Surgery 2016; 159(4): 1050 doi: 10.1016/j.surg.2015.10.008
|
| 57 |
Alban Zarzavadjian Le Bian, Christine Denet, Nicolas Tabchouri, Gianfranco Donatelli, Philippe Wind, Christophe Louvet, Mostefa Bennamoun, Christos Christidis, Thierry Perniceni, David Fuks, Brice Gayet. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients. Langenbeck's Archives of Surgery 2018; 403(4): 443 doi: 10.1007/s00423-018-1677-y
|